Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2014

Open Access 01-12-2014 | Original research article

Diagnostic utility of serum and pleural levels of adenosine deaminase 1–2, and interferon-γ in the diagnosis of pleural tuberculosis

Authors: Sibel Yurt, Canan Küçükergin, Burcu Arpinar Yigitbas, Şule Seçkin, Hüseyin Cem Tigin, Ayşe Filiz Koşar

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2014

Login to get access

Abstract

Background

To evaluate and compare the diagnostic efficiency of serum (s) and pleural (p) levels of adenosine deaminase (ADA)-1, ADA-2, total ADA, and interferon-gamma (IFN-γ) for the differential diagnosis of pleural tuberculosis (TB).

Methods

Clinical and analytic data of 93 consecutive patients with pleural effusions from May 2012 to February 2013 were prospectively evaluated. The study population included 43 pleural TB, 23 malignancies, and 27 other exudates. The median and interquartile range of ADA-1, ADA-2, total ADA, and IFN-γ were evaluated according to their underlying diseases.

Results

There were no significant differences in sADA-1 and sIFN-γ values among each group. pADA-1, pADA-2, total pADA, and pIFN-γ levels were significantly higher in patients with pleural TB than in other patients (p < 0.0001). As for pleural TB receiving operating characteristic (ROC) curves identified the following results. The best cut-off value for pADA-2 was 20.37 U/L and it yielded a sensitivity and specificity of 95.35% and 86%, respectively. Taking a cut-off value of 40.68 U/L for total pADA, the sensitivity and the specificity were found to be 88.37% and 88%, respectively. ROC curve identified 110 U/L as the best cut-off value for pμg/ml, while the sensitivity and the specificity were 74.42% and 68%, respectively. Finally, the best cut-off value for pADA-1 was 16.8 U/L and yielded a sensitivity and specificity of 69.77% and 68%, respectively.

Conclusions

To distinguish pleural TB, pleural levels of ADA-2 have the highest sensitivity among the different diagnostic parameters and may find a place as routine investigation for early detection of TB in the future.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rosso F, Michelon CT, Sperhacke RD, Verza M, Olival L, Conde MB, Guerra RL, Zaha A, Rossetti ML: Evaluation of real-time PCR of patient pleural effusion for diagnosis of tuberculosis. BMC Res Notes. 2011, 4: 279-10.1186/1756-0500-4-279.PubMedCentralCrossRefPubMed Rosso F, Michelon CT, Sperhacke RD, Verza M, Olival L, Conde MB, Guerra RL, Zaha A, Rossetti ML: Evaluation of real-time PCR of patient pleural effusion for diagnosis of tuberculosis. BMC Res Notes. 2011, 4: 279-10.1186/1756-0500-4-279.PubMedCentralCrossRefPubMed
2.
go back to reference Villegas MV, Labrada LA, Saravia NG: Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest. 2000, 118: 1355-1364. 10.1378/chest.118.5.1355.CrossRefPubMed Villegas MV, Labrada LA, Saravia NG: Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest. 2000, 118: 1355-1364. 10.1378/chest.118.5.1355.CrossRefPubMed
3.
go back to reference Pal S, Gupta S: Adenosine deaminase-the non-invasive marker of tuberculosis. J Indian Med Assoc. 2012, 110 (1): 16-18.PubMed Pal S, Gupta S: Adenosine deaminase-the non-invasive marker of tuberculosis. J Indian Med Assoc. 2012, 110 (1): 16-18.PubMed
4.
go back to reference Valdes L, San Jose E, Alvarez D ES, Valle JM: Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J. 1996, 9: 747-751. 10.1183/09031936.96.09040747.CrossRefPubMed Valdes L, San Jose E, Alvarez D ES, Valle JM: Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J. 1996, 9: 747-751. 10.1183/09031936.96.09040747.CrossRefPubMed
5.
go back to reference Aoe K, Hiraki A, Murakami T, Eda R, Maeda T, Sugi K, Takeyama H: Diagnostic significance of interferon-g in tuberculous pleural effusions. Chest. 2003, 123: 740-744. 10.1378/chest.123.3.740.CrossRefPubMed Aoe K, Hiraki A, Murakami T, Eda R, Maeda T, Sugi K, Takeyama H: Diagnostic significance of interferon-g in tuberculous pleural effusions. Chest. 2003, 123: 740-744. 10.1378/chest.123.3.740.CrossRefPubMed
6.
go back to reference Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL: Local production of tumor necrosis factor and IFN-γ in tuberculouspleuritis. J Immunol. 1990, 145: 149-154.PubMed Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL: Local production of tumor necrosis factor and IFN-γ in tuberculouspleuritis. J Immunol. 1990, 145: 149-154.PubMed
7.
go back to reference Light RW, Macgregor MI, Luchsinger PC, Ball WC: Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972, 77: 507-513. 10.7326/0003-4819-77-4-507.CrossRefPubMed Light RW, Macgregor MI, Luchsinger PC, Ball WC: Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972, 77: 507-513. 10.7326/0003-4819-77-4-507.CrossRefPubMed
8.
go back to reference Giusti G, Galanti B: Methods of Enzymatic Analysis. 1984, Weinheim: VerlagChemie, 315 Giusti G, Galanti B: Methods of Enzymatic Analysis. 1984, Weinheim: VerlagChemie, 315
9.
go back to reference Ellis G, Goldberg DM: A reduced nicotinamide adenine dinucleotide linked kinetic assay for adenosine deaminase activity. J Lab Clin Med. 1970, 76: 507-517.PubMed Ellis G, Goldberg DM: A reduced nicotinamide adenine dinucleotide linked kinetic assay for adenosine deaminase activity. J Lab Clin Med. 1970, 76: 507-517.PubMed
10.
go back to reference Rothel JS, Andersen P: Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?. Expert Rev Anti Infect Ther. 2005, 3: 981-993. 10.1586/14787210.3.6.981.CrossRefPubMed Rothel JS, Andersen P: Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?. Expert Rev Anti Infect Ther. 2005, 3: 981-993. 10.1586/14787210.3.6.981.CrossRefPubMed
11.
go back to reference Pai M, Riley LW, Colford JM: Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004, 4: 761-776. 10.1016/S1473-3099(04)01206-X.CrossRefPubMed Pai M, Riley LW, Colford JM: Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004, 4: 761-776. 10.1016/S1473-3099(04)01206-X.CrossRefPubMed
12.
go back to reference Jiang J, Shi HZ, Liang QL, Qin SM, Qin XJ: Diagnostic value of interferon-γ in tuberculous pleurisy: a meta-analysis. Chest. 2007, 131: 1133-1141. 10.1378/chest.06-2273.CrossRefPubMed Jiang J, Shi HZ, Liang QL, Qin SM, Qin XJ: Diagnostic value of interferon-γ in tuberculous pleurisy: a meta-analysis. Chest. 2007, 131: 1133-1141. 10.1378/chest.06-2273.CrossRefPubMed
13.
go back to reference Trajman A, Kaisermann C, Luiz RR, Sperhacke RD, Rossetti ML, FéresSaad MH, Sardella IG, Spector N, Kritski AL: Pleural fluid ADA, IgA-ELISA, and PCR sensitivities for the diagnosis of pleural tuberculosis. Scand J Lab Clin Invest. 2007, 67: 877-884. 10.1080/00365510701459742.CrossRef Trajman A, Kaisermann C, Luiz RR, Sperhacke RD, Rossetti ML, FéresSaad MH, Sardella IG, Spector N, Kritski AL: Pleural fluid ADA, IgA-ELISA, and PCR sensitivities for the diagnosis of pleural tuberculosis. Scand J Lab Clin Invest. 2007, 67: 877-884. 10.1080/00365510701459742.CrossRef
14.
go back to reference Ocaña I, Martínez-Vázquez JM, Ribera E, Segura R, Pascual C: Adenosine deaminase activity in the diagnosis of lymphocytic pleural effusions of tuberculous, neoplastic and lymphomatous origin. Tubercle. 1986, 67: 141-145. 10.1016/0041-3879(86)90008-5.CrossRefPubMed Ocaña I, Martínez-Vázquez JM, Ribera E, Segura R, Pascual C: Adenosine deaminase activity in the diagnosis of lymphocytic pleural effusions of tuberculous, neoplastic and lymphomatous origin. Tubercle. 1986, 67: 141-145. 10.1016/0041-3879(86)90008-5.CrossRefPubMed
15.
go back to reference Ocaña I, Ribera E, Bejarano E, Fernandezde Sevilla T, Español T, Martínez-Vázquez JM: Subpoblacioneslinfocitarias en los derramespleurales: relación con la actividad de ADA. Ann Med Intern (Madrid). 1988, 6: 274-278. Ocaña I, Ribera E, Bejarano E, Fernandezde Sevilla T, Español T, Martínez-Vázquez JM: Subpoblacioneslinfocitarias en los derramespleurales: relación con la actividad de ADA. Ann Med Intern (Madrid). 1988, 6: 274-278.
16.
go back to reference Gakis C, Calia G, Naitana A, Pirino D, Serru G: Serum adenosine deaminase activity in HIV positive subjects: a hypothesis on the significance of ADA-2. Panminerva Med. 1989, 31: 107-113.PubMed Gakis C, Calia G, Naitana A, Pirino D, Serru G: Serum adenosine deaminase activity in HIV positive subjects: a hypothesis on the significance of ADA-2. Panminerva Med. 1989, 31: 107-113.PubMed
17.
go back to reference Ungerer JPJ, Oosthuizen HM, Bissbort SH, Vermaak WJH: Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992, 38: 1322-1326.PubMed Ungerer JPJ, Oosthuizen HM, Bissbort SH, Vermaak WJH: Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992, 38: 1322-1326.PubMed
18.
go back to reference Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C: Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis. 2003, 7: 777-786.PubMed Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C: Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis. 2003, 7: 777-786.PubMed
19.
go back to reference Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ: Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med. 2008, 102: 744-754. 10.1016/j.rmed.2007.12.007.CrossRefPubMed Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ: Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med. 2008, 102: 744-754. 10.1016/j.rmed.2007.12.007.CrossRefPubMed
20.
go back to reference Zarić B, Kuruc V, Milovancev A, Markovic M, Sarcev T, Canak V, Pavlović S: Differential diagnosis of tuberculous and malignant pleural effusions: What is the role of adenosine deaminase?. Lung. 2008, 186 (4): 233-240. 10.1007/s00408-008-9085-7.CrossRefPubMed Zarić B, Kuruc V, Milovancev A, Markovic M, Sarcev T, Canak V, Pavlović S: Differential diagnosis of tuberculous and malignant pleural effusions: What is the role of adenosine deaminase?. Lung. 2008, 186 (4): 233-240. 10.1007/s00408-008-9085-7.CrossRefPubMed
21.
go back to reference Hirschorn R, Ratech H: Isozymes of adenosine deaminase. Curr Top Biol Med Res. 1980, 4: 131-157. Hirschorn R, Ratech H: Isozymes of adenosine deaminase. Curr Top Biol Med Res. 1980, 4: 131-157.
22.
go back to reference Ungerer JP, Grobler SM: Molecular forms of adenosine deaminase in pleural fluids. Enzyme. 1988, 40: 7-13.PubMed Ungerer JP, Grobler SM: Molecular forms of adenosine deaminase in pleural fluids. Enzyme. 1988, 40: 7-13.PubMed
23.
go back to reference Kurata N, Kihara M, Matsubayashi K, Kase K, Haneda M: Activities and isozymes of adenosine deaminase and lactate dehydrogenase in tuberculous pleural effusion with special reference to Mycobacterium Tuberculosis. Rinsho Byori. 1992, 40: 670-672.PubMed Kurata N, Kihara M, Matsubayashi K, Kase K, Haneda M: Activities and isozymes of adenosine deaminase and lactate dehydrogenase in tuberculous pleural effusion with special reference to Mycobacterium Tuberculosis. Rinsho Byori. 1992, 40: 670-672.PubMed
24.
go back to reference Ungerer JPJ, Oosthuizen HM, Retief JH, Bissbort SH: Significance of adenosine deaminase and its isoenzymes in tuberculous effusions. Chest. 1994, 106: 33-37. 10.1378/chest.106.1.33.CrossRefPubMed Ungerer JPJ, Oosthuizen HM, Retief JH, Bissbort SH: Significance of adenosine deaminase and its isoenzymes in tuberculous effusions. Chest. 1994, 106: 33-37. 10.1378/chest.106.1.33.CrossRefPubMed
25.
go back to reference Chen YM, Yang WK, Whang-Peng J, Tsai CH, Perng RP: An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer. 2001, 31: 25-30. 10.1016/S0169-5002(00)00165-3.CrossRefPubMed Chen YM, Yang WK, Whang-Peng J, Tsai CH, Perng RP: An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer. 2001, 31: 25-30. 10.1016/S0169-5002(00)00165-3.CrossRefPubMed
26.
go back to reference Soderblom T, Nyberg P, Teppo AM, Klockars M, Riska H, Pettersson T: Pleural fluid interferon-gamma and tumor necrosis factor-a in tuberculous and rheumatoid pleurisy. Eur Respir J. 1996, 9: 1652-1655. 10.1183/09031936.96.09081652.CrossRefPubMed Soderblom T, Nyberg P, Teppo AM, Klockars M, Riska H, Pettersson T: Pleural fluid interferon-gamma and tumor necrosis factor-a in tuberculous and rheumatoid pleurisy. Eur Respir J. 1996, 9: 1652-1655. 10.1183/09031936.96.09081652.CrossRefPubMed
Metadata
Title
Diagnostic utility of serum and pleural levels of adenosine deaminase 1–2, and interferon-γ in the diagnosis of pleural tuberculosis
Authors
Sibel Yurt
Canan Küçükergin
Burcu Arpinar Yigitbas
Şule Seçkin
Hüseyin Cem Tigin
Ayşe Filiz Koşar
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2014
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/2049-6958-9-12

Other articles of this Issue 1/2014

Multidisciplinary Respiratory Medicine 1/2014 Go to the issue

Reviewer acknowledgement

Reviewer acknowledgement 2013

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.